8. Ceva Santé Animale – Top 10 animal health companies

A cow and dog touching noses

Ceva logoCeva Santé Animale
2015 Revenue: $937 million (€857 million)
HQ: Libourne, France

Marc Prikazsky, CEO of France’s Ceva Santé Animale, has made no secret of the fact that he wants his company to break into the top 5 animal health leaders by 2020. If 2015 is any indication, the company is well on its way to reaching that goal. Ceva’s revenues grew 12% in 2015, thanks in part to strong demand for its poultry vaccines Vectormune ND and Transmune. The company invests 10% of its turnover into R&D. In 2014, it launched an $8 million expansion of its U.S. business and it’s investing €80 million in 2016 in France, the U.S., Hungary and other countries. Ceva has also been hot on the acquisition trail, picking up its French neighbor Biovac, a vaccine maker, as well as Polchem, an India-based company that will help Ceva gain ground in that country’s rapidly growing poultry and dairy industries.

Related Articles: 
Ceva makes strides toward animal health dominance with strong 2015 sales
Ceva builds on vaccine expertise with Biovac buy
Ceva vows an ‘extremely responsive’ approach to U.S. animal health market

8. Ceva Santé Animale – Top 10 animal health companies
Read more on

Suggested Articles

Pfizer spinoff Zoetis met Q2 expectations and brightened its full-year forecast, but it's looking to M&A to drive further growth.

Fresenius’ new CEO has pulled off a dealmaking double play, committing more than $5.4 billion to expand its reach in both sterile generics and in biosimilars.

Bayer’s pharma products have been growing lickety-split, and its 2016 numbers show just how—and how much. But with the big Monsanto merger top of mind at Bayer…